医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

The 12th Annual International Bioethics Forum Brings Experts to Explore Creative Insight: Further Studies in Human Consciousness

2013年01月18日 AM04:25
このエントリーをはてなブックマークに追加


 

MADISON, Wis.

Join scientists, artists and other global experts as they share their insights on creativity and consciousness during the two-day 12th Annual International Bioethics Forum held April 25-26, 2013 in Madison, Wisconsin.

WHAT:

  The 12th Annual International Bioethics Forum, a yearly event dedicated to sharing scientific information and exploring its social and ethical implications
 

THEME:

Creative Insight: Further Studies in Human Consciousness
 

WHEN:

April 25-26, 2013
 

WHERE:

BioPharmaceutical Technology Center, Promega Corporation
5445 East Cheryl Parkway, Fitchburg, WI 53711
 

WHO:

Co-hosted by the BioPharmaceutical Technology Center Institute and Promega Corporation.

CONFIRMED PRESENTERS:

  • Lynda Barry: Cartoonist, artist, author and speaker (Rock County, WI)
  • Erik Davis: Cultural critic, freelance journalist and lecturer (Redwood City, CA)
  • James Fadiman, Ph.D.: Adjunct full professor, Institute of Transpersonal Psychology (Palo Alto, CA)
  • Scott Barry Kaufman, Ph.D.: Adjunct assistant professor of psychology, New York University (New York, NY)
  • David Krakauer, Ph.D.: Director, Wisconsin Institute for Discovery (Madison, WI)
  • Alfonso Montuori, Ph.D.: Professor and department chair, California Institute of Integral Studies (San Francisco, CA)
  • Matthieu Ricard: Monk, Shechen Tennyi Dargyeling Monastery (near Kathmandu, Nepal)

The 12th Annual International Bioethics Forum is open to the general public but limited to 350 participants. Registration to open in early February. For more information or to register, please visit: http://www.btci.org/bioethics/.

About BTCI

The BioPharmaceutical Technology Center Institute (BTCI) is a not-for-profit organization operated exclusively for educational, scientific and cultural purposes. Learn more about its K-12 programs, scientific course offerings, and annual educational forums and symposiums at http://www.btci.org/.

CONTACT

The BioPharmaceutical Technology Center Institute
Karin Borgh,
(608) 277-2508
karin.borgh@btci.org

同じカテゴリーの記事 

  • La Jolla Institute for Immunology and RevolKa started a Research Collaboration
  • U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
  • ESCMID Global 2024: Shionogi presents real-world data demonstrating efficacy of Fetcroja® / Fetroja® (cefiderocol) in critically ill patients with certain difficult-to-treat bacterial infections
  • Renesas’ New FemtoClock™ 3 Timing Solution Delivers Industry’s Lowest Power and Leading Jitter Performance of 25fs-rms
  • 成人向け予防接種プログラムは初期投資の19倍もの社会経済的価値をもたらすとの新レポートを発表